Rhophylac 300, Injektionslösung

7680536090237 CH-53609 Injektionslösung
Rhophylac 300, Injektionslösung
Rhophylac 300, Injektionslösung
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
1
Selling units
1
Measure
Spritze(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
14/05/2026
Summary of Product Characteristics
Français
14/05/2026
Summary of Product Characteristics
Italien
14/05/2026

Detailed composition

Substance Quantity Type Category
immunoglobulinum humanum anti-D
300.0 UG Substance Wirkstoff (Principe actif)
proteina plasmatis humani
- Substance HNIDK
albuminum humanum
- Substance HNIDK
glycinum
- Substance HNIDK
natrii chloridum
- Substance HNIDK
natrium
- Substance HBESI
acidum aceticum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 87.90
Specialties list
Yes
Generic
No
SL addition date: 01/01/2002

Authorization holder

CSL Behring AG

3014 Bern

Authorization information

Swissmedic authorization number
53609
Drug name
Rhophylac, Injektionslösung
Galenic form
LSPA
ATC Code
J06BB01
Authorization status
Z
Dispensing category
B
First authorization
08/03/1996
Authorization expiration date
31/12/9999
IT Number
08.09.
Domain
Human medicine
Field of application
Prophylaxe der Rhesusimmunisierung

Package details

Description (FR)
RHOPHYLAC sol inj 300 µg 2 ml PFS
Description (DE)
RHOPHYLAC Inj Lös 300 µg 2 ml PFS
Market launch
14/09/2001
Narcotic (BTM)
No

Application methods

IV IMU

Other package sizes (1)

RHOPHYLAC sol inj 200 mcg ser prête 2 ml
1 SPRI
GTIN: 7680536090152
Not in V1
Buy us a coffee Explore the data